A price-fixing case against kidney doctors in Puerto Rico initiated by the Federal Trade Commission has come to a settlement, according to reports. The FTC brought charges against the doctors, alleging they had colluded with a Humana Inc health plan to raise reimbursement rates; when those demands were not met, the doctors reportedly refused to treat patients of Humana. It was a scheme that resulted in at least one case of a patient being turned away to another hospital suffering from critical renal failure, said the FTC. According to reports, the settlement prohibits the eight doctors – who make up 90 percent of the nephrologists in southwestern Puerto Rico – from colluding with health insurers and refusing to treat patients.
Featured News
Paramount Seeks to Address Regulatory Concerns Over Warner Bros. Discovery Deal
Jun 8, 2026 by
CPI
Italy Ends Meta WhatsApp AI Probe as EU Investigation Expands
Jun 8, 2026 by
CPI
Both Left and Right in Washington Eye Public Equity Stakes in AI Companies
Jun 8, 2026 by
CPI
Democrats Roll Out Wave of AI Bills as Voter Concerns Mount
Jun 8, 2026 by
CPI
House Judiciary Committee Report Accuses NFL of Misusing Antitrust Exemption
Jun 8, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani